Accipiter Biosciences designs and develops de novo protein therapies — unbound by natural limitations — to address the world’s most complex diseases. Our single-agent biologics are custom-engineered to engage multiple […]
Accipiter Biosciences designs and develops de novo protein therapies — unbound by natural limitations — to address the world’s most complex diseases. Our single-agent biologics are custom-engineered to engage multiple […]